Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

Tainsky MA.

Biochim Biophys Acta. 2009 Dec;1796(2):176-93. doi: 10.1016/j.bbcan.2009.04.004. Epub 2009 May 4. Review.

2.

Proteomics of cancer of hormone-dependent tissues.

Tyson DR, Ornstein DK.

Adv Exp Med Biol. 2008;630:133-47. Review.

PMID:
18637489
3.

Proteomic Approaches for Biomarker Panels in Cancer.

Tanase C, Albulescu R, Neagu M.

J Immunoassay Immunochem. 2016;37(1):1-15. doi: 10.1080/15321819.2015.1116009. Review.

PMID:
26565430
4.

The footprints of cancer development: Cancer biomarkers.

Ullah MF, Aatif M.

Cancer Treat Rev. 2009 May;35(3):193-200. doi: 10.1016/j.ctrv.2008.10.004. Epub 2008 Dec 4. Review.

PMID:
19062197
5.

Inconvenient truth: cancer biomarker development by using proteomics.

Kondo T.

Biochim Biophys Acta. 2014 May;1844(5):861-5. doi: 10.1016/j.bbapap.2013.07.009. Epub 2013 Jul 27. Review.

PMID:
23896458
6.

Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.

Mohri Y, Toiyama Y, Kusunoki M.

Expert Rev Proteomics. 2016 Dec;13(12):1131-1139. Epub 2016 Oct 31. Review.

PMID:
27744719
7.

Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.

Boja ES, Fehniger TE, Baker MS, Marko-Varga G, Rodriguez H.

J Proteome Res. 2014 Dec 5;13(12):5325-32. doi: 10.1021/pr500753r. Epub 2014 Nov 18. Review.

8.

Emerging blood-based biomarkers for detection of gastric cancer.

Kalniņa Z, Meistere I, Kikuste I, Tolmanis I, Zayakin P, Linē A.

World J Gastroenterol. 2015 Nov 7;21(41):11636-53. doi: 10.3748/wjg.v21.i41.11636. Review.

9.

New cancer biomarkers deriving from NCI early detection research.

Verma M, Srivastava S.

Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.

PMID:
12903844
10.

Biomarker research with prospective study designs for the early detection of cancer.

Pesch B, Brüning T, Johnen G, Casjens S, Bonberg N, Taeger D, Müller A, Weber DG, Behrens T.

Biochim Biophys Acta. 2014 May;1844(5):874-83. doi: 10.1016/j.bbapap.2013.12.007. Epub 2013 Dec 17. Review.

PMID:
24361552
11.

Proteomics of endometrial cancer diagnosis, treatment, and prognosis.

Mittal P, Klingler-Hoffmann M, Arentz G, Zhang C, Kaur G, Oehler MK, Hoffmann P.

Proteomics Clin Appl. 2016 Mar;10(3):217-29. doi: 10.1002/prca.201500055. Epub 2015 Dec 15. Review.

PMID:
26541900
12.

Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.

Lutz AM, Willmann JK, Cochran FV, Ray P, Gambhir SS.

PLoS Med. 2008 Aug 19;5(8):e170. doi: 10.1371/journal.pmed.0050170.

13.

Proteomic contributions to personalized cancer care.

Koomen JM, Haura EB, Bepler G, Sutphen R, Remily-Wood ER, Benson K, Hussein M, Hazlehurst LA, Yeatman TJ, Hildreth LT, Sellers TA, Jacobsen PB, Fenstermacher DA, Dalton WS.

Mol Cell Proteomics. 2008 Oct;7(10):1780-94. doi: 10.1074/mcp.R800002-MCP200. Epub 2008 Jul 29. Review.

14.

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.

Ostroff RM, Bigbee WL, Franklin W, Gold L, Mehan M, Miller YE, Pass HI, Rom WN, Siegfried JM, Stewart A, Walker JJ, Weissfeld JL, Williams S, Zichi D, Brody EN.

PLoS One. 2010 Dec 7;5(12):e15003. doi: 10.1371/journal.pone.0015003.

15.

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.

Kulasingam V, Diamandis EP.

Nat Clin Pract Oncol. 2008 Oct;5(10):588-99. doi: 10.1038/ncponc1187. Epub 2008 Aug 12. Review.

PMID:
18695711
16.

Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.

Irimie AI, Braicu C, Cojocneanu-Petric R, Berindan-Neagoe I, Campian RS.

Acta Odontol Scand. 2015 Apr;73(3):161-8. doi: 10.3109/00016357.2014.986754. Epub 2015 Jan 19. Review.

PMID:
25598447
17.

Fast proteomic protocol for biomarker fingerprinting in cancerous cells.

Armenta JM, Perez M, Yang X, Shapiro D, Reed D, Tuli L, Finkielstein CV, Lazar IM.

J Chromatogr A. 2010 Apr 23;1217(17):2862-70. doi: 10.1016/j.chroma.2010.02.065. Epub 2010 Mar 3.

18.

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Shukla HD, Mahmood J, Vujaskovic Z.

Cancer Lett. 2015 Dec 1;369(1):28-36. doi: 10.1016/j.canlet.2015.08.003. Epub 2015 Aug 11. Review.

PMID:
26276717
19.

Proteomics for the identification of new prostate cancer biomarkers.

Ornstein DK, Tyson DR.

Urol Oncol. 2006 May-Jun;24(3):231-6. Review.

PMID:
16678055
20.

Enzymes and related proteins as cancer biomarkers: a proteomic approach.

Liang SL, Chan DW.

Clin Chim Acta. 2007 May;381(1):93-7. Epub 2007 Feb 20. Review.

Supplemental Content

Support Center